Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders Growth (5y) (2014 - 2023)
Dr Reddys Laboratories (RDY) Net Income towards Common Stockholders Growth (5y) (2014 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.47 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 20.87% |
| Mar 31, 2023 | 21.82% |
| Dec 31, 2022 | 21.60% |
| Sep 30, 2022 | -92.15% |
| Mar 31, 2021 | -3.71% |
| Sep 30, 2020 | -26.41% |
| Jun 30, 2020 | 6.26% |
| Sep 30, 2019 | -23.01% |
| Mar 31, 2019 | 0.43% |
| Dec 31, 2018 | -7.89% |
| Sep 30, 2018 | -6.89% |
| Jun 30, 2018 | -60.19% |
| Mar 31, 2018 | 0.65% |
| Dec 31, 2017 | -15.97% |
| Sep 30, 2017 | -11.51% |
| Dec 31, 2016 | -57.41% |
| Sep 30, 2016 | -62.08% |
| Mar 31, 2016 | 9.53% |
| Dec 31, 2015 | -5.04% |
| Sep 30, 2015 | 22.50% |